Prentice Wealth Management LLC Exelixis, Inc. Transaction History

Prentice Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$17.44 - $23.16 $4,673 - $6,206	-268 Reduced 38.29%	432 $9,000
Q2 2021 Aug 11, 2021	SELL	$17.95 - $25.56 $592 - $843	-33 Reduced 4.5%	700 $13,000
Q1 2021 Jun 17, 2021	SELL	$20.53 - $25.22 $324,887 - $399,106	-15,825 Reduced 95.57%	733 $17,000
Q1 2021 Jun 08, 2021	BUY	$20.53 - $25.22 $339,935 - $417,592	16,558 New	16,558 $17,000

520

244M

2.84M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prentice Wealth Management LLC with notifications on news.